MedTrace Logo

the Role of ctDNA in Predicting the Recurrence Risk of Colorectal Cancer

NCT05131243 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-11-23

No results posted yet for this study

Summary

The purpose of this study was to observe the relationship between ctDNA as a molecular marker of colorectal cancer and the risk of postoperative recurrence.

Conditions

  • Colorectal Cancer Stage II
  • Colorectal Cancer Stage III

Interventions

PROCEDURE

Chemotherapy time

6 months of chemotherapy

PROCEDURE

Chemotherapy time

3 months of chemotherapy

Sponsors & Collaborators

  • Fujian Cancer Hospital

    lead OTHER_GOV

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2023-05-01
Completion
2023-05-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05131243 on ClinicalTrials.gov